Numerous factors can contribute to the failure of potentially effective drugs to demonstrate efficacy. These include flawed study designs, inappropriate statistical endpoints, and underpowered clinical trials with small sample sizes that cannot reject the null hypothesis. Additionally, patient dropouts can further exacerbate these challenges.